NICE (NICE) Stock Price Target 2026

The average analyst price target for NICE is $164.80, 67.3% above the current price. Of 16 analysts, 11 rate it Buy and 5 Hold. Targets range from $100 to $300. The latest change came on Nov 5, 2026, when RBC Capital lowered its price target on NICE from $145 to $130 and kept an Outperform rating.

The Average Analyst Price Target for NICE is $164.80.

Price Target Range — 11 Quarters

Analyst Consensus — 16 Analysts

3S.Buy

8Buy

5Hold

Consensus RatingNeutral# Analysts16Avg. Consensus PT$164.80Upside to Avg. PT+67.3%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for NICE Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 5, 2026	RBC Capital	Rishi Jaluria	PT Cut	Outperform	$145→$130
Nov 5, 2026	Citizens	Patrick Walravens	PT Cut	Market Outperform	$170→$158
Sep 30, 2026	Oppenheimer	Timothy Horan	Upgrade	Perform→Outperform	$150
Sep 24, 2026	RBC Capital	Rishi Jaluria	PT Raise	Outperform	$130→$145
Aug 6, 2026	DA Davidson	Clark Wright	PT Raise	Buy	$110→$115
Aug 6, 2026	Rosenblatt	Catharine Trebnick	Maintained	Buy	$130
Jul 21, 2026	Morgan Stanley	Elizabeth Porter	Downgrade	Overweight→Equal-Weight	$130→$111
Jun 18, 2026	DA Davidson	Clark Wright	Upgrade	Neutral→Buy	$110
Jun 10, 2026	RBC Capital	Rishi Jaluria	Maintained	Outperform	$130
Jun 10, 2026	Wedbush	Dan Ives	PT Cut	Neutral	$120→$100
Jun 10, 2026	Cantor Fitzgerald	Thomas Blakey	Maintained	Neutral	$104
Jun 10, 2026	Rosenblatt	Catharine Trebnick	Maintained	Buy	$155
May 11, 2026	Morgan Stanley	Hamza Fodderwala	PT Cut	Overweight	$148→$130
May 8, 2026	Citigroup	Tyler Radke	PT Cut	Neutral	$119→$100
May 7, 2026	DA Davidson	Clark Wright	PT Cut	Neutral	$125→$110
May 7, 2026	RBC Capital	Rishi Jaluria	PT Cut	Outperform	$150→$130
May 7, 2026	Citizens	Patrick Walravens	PT Cut	Market Outperform	$200→$170
Apr 10, 2026	Citigroup	Tyler Radke	Downgrade	Buy→Neutral	$184→$119
Mar 10, 2026	DA Davidson	Clark Wright	PT Cut	Neutral	$130→$125
Feb 20, 2026	Wedbush	Daniel Ives	Maintained	Neutral	$120